Clinical Characteristics and Prognostic Factors in Patients With Meningitis at Sohag Governorate.

August 12, 2026 updated by: Yehia Atef Khalifa Elsayed, Sohag University

Analyze of Clinical Characteristics and Prognostic Factors in Patients With Meningitis at Sohag Governorate

analyze the clinical characteristics and prognostic factors in patients with meningitis at Sohag Governorate .This is an ambidirectional (retrospective and prospective), hospital-based observational study. The study involves a retrospective review of patient records over the past 3 years, combined with a prospective recruitment of new patients for one year from the initiation of the study

Study Overview

Status

Not yet recruiting

Conditions

Meningitis

Study Type

Observational

Enrollment (Estimated)

300

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Name: YEHIA ATEF
Phone Number: 20010333109026
Email: yehiaatef183@gmail.com

Study Locations

Egypt
- Egypt
  - Sohag, Egypt, Egypt, 20
    - Sohag Fever Hospital
    - Contact:
      
      يحيي عاطف

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

Child
Adult
Older Adult

Accepts Healthy Volunteers

Sampling Method

Non-Probability Sample

Study Population

All patients diagnosed with meningitis and admitted to Sohag Fever Hospital during the study period, regardless of age or sex, who meet the study eligibility criteria.

Description

Inclusion Criteria:

All patients diagnosed with meningitis admitted to Sohag Fever Hospital during the study period.
Patients of all age groups and both sexes.
Patients with confirmed diagnosis based on clinical features and CSF analysis.

Exclusion Criteria:

Patients with incomplete medical records.
Patients with uncertain diagnosis of meningitis.
Patients discharged against medical advice before completion of evaluation.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
All-cause in-hospital mortality Time Frame: From hospital admission until hospital discharge, up to 30 days.	Death from any cause occurring during hospitalization, reported as the number and percentage of participants who died during hospital admission.	From hospital admission until hospital discharge, up to 30 days.

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Recovery without neurological sequelae at hospital discharge Time Frame: From hospital admission until hospital discharge, up to 30 days.	Number and percentage of participants who recover from meningitis without documented neurological sequelae at hospital discharge.	From hospital admission until hospital discharge, up to 30 days.
Neurological sequelae at hospital discharge Time Frame: From hospital admission until hospital discharge, up to 30 days.	Number and percentage of participants with documented neurological sequelae related to meningitis at hospital discharge.	From hospital admission until hospital discharge, up to 30 days.
In-hospital complications Time Frame: From hospital admission until hospital discharge, up to 30 days.	Number and percentage of participants who develop complications during hospitalization, with the type of complication recorded.	From hospital admission until hospital discharge, up to 30 days.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sohag University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

August 15, 2026

Primary Completion (Estimated)

August 15, 2027

Study Completion (Estimated)

November 15, 2027

Study Registration Dates

First Submitted

August 2, 2026

First Submitted That Met QC Criteria

August 12, 2026

First Posted (Actual)

August 17, 2026

Study Record Updates

Last Update Posted (Actual)